IP Library Granted Patent US 8,603,050
Granted Patent B2
US 8,603,050 · App. 11/759,882 · Granted Dec 10, 2013

Implantable infusion devices including apparatus for confirming side port access

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,603,050
App. No.
11/759,882
Granted
Dec 10, 2013
Kind
B2
Abstract

Implantable infusion devices and systems with side port access detection capability and methods of detecting side port access. The methods may include the steps of sensing pressure in a fluid passage between an implanted pump mechanism and an implanted outlet port and determining that an implanted side port has been accessed by a hypodermic needle based on a predetermined change in pressure in the fluid passage between the implanted pump mechanism and the implanted outlet port.

Claims (53)

1. A method for use with an implanted infusion device and syringe that is not part of the implanted infusion device, the implanted infusion device including an implanted reservoir refill port, an implanted reservoir connected to the implanted reservoir refill port, an implanted pump mechanism connected to the implanted reservoir, an implanted outlet port configured to have a catheter connected thereto, a fluid passage between the implanted pump mechanism and the implanted outlet port that connects the implanted pump mechanism to the implanted outlet port, an implanted side port connected to the fluid passage at a location between the implanted pump mechanism and the implanted outlet port, and a pressure sensor connected to the fluid passage at a location between the implanted pump mechanism and the implanted outlet port, and the syringe including a plunger and a hypodermic needle, the method comprising the steps of:

sensing pressure in the fluid passage between the implanted pump mechanism and the implanted outlet port with the pressure sensor; and

determining that the implanted side port has been accessed by the hypodermic needle based on a predetermined change in the pressure in the fluid passage between the implanted pump mechanism and the implanted outlet port sensed by the pressure sensor.

2. A method as claimed in claim 1 , further comprising the step of:

providing a visible indication that the side port has been accessed.

3. A method as claimed in claim 1 , further comprising the steps of:

sensing a baseline pressure in the fluid passage with the pressure sensor; and

monitoring pressure in the fluid passage with the pressure sensor after the baseline pressure measurement has been sensed;

wherein the predetermined change in pressure is a predetermined difference between the baseline pressure and the pressure monitored after the baseline pressure measurement.

4. A method as claimed in claim 3 , wherein

the predetermined change in pressure comprises a pressure increase from the baseline pressure of a predetermined magnitude.

5. A method as claimed in claim 3 , wherein

the predetermined change in pressure comprises a pressure decrease from the baseline pressure of a predetermined magnitude.

6. A method as claimed in claim 4 , wherein

the predetermined change in pressure comprises a pressure increase of at least 3 psi from the baseline pressure.

7. A method for use with an implanted infusion device, a controller, and a syringe that is not part of the implanted infusion device, the implanted infusion device including an implanted reservoir refill port, an implanted reservoir connected to the implanted reservoir refill port, an implanted pump mechanism connected to the implanted reservoir, an implanted outlet port configured to have a catheter connected thereto, a fluid passage between the implanted pump mechanism and the implanted outlet port that connects the implanted pump mechanism to the implanted outlet port, an implanted side port connected to the fluid passage at a location between the implanted pump mechanism and the implanted outlet port, and a pressure sensor connected to the passage at a location between the implanted pump mechanism and the implanted outlet port, the controller being operably connected to the pressure sensor, and the syringe including a plunger and a hypodermic needle, the method comprising the steps of:

sensing a baseline pressure in the fluid passage with the pressure sensor;

continuing to sense pressure with the pressure sensor after the baseline pressure has been sensed;

determining, with the controller, that the hypodermic needle has entered the implanted side port in response to a predetermined decrease in pressure in the fluid passage from the baseline pressure in the fluid passage; and

providing an audible and/or visible indication that the side port has been accessed in response to a determination that the hypodermic needle has entered the side port.

8. A method as claimed in claim 7 , further comprising the step of:

initiating a side port monitoring period in response to a signal from a remote device;

wherein the predetermined decrease in pressure from a baseline pressure comprises a predetermined decrease in pressure from a baseline pressure that occurs during the side port monitoring period.

9. A method as claimed in claim 7 , further comprising the steps of:

taking a baseline pressure measurement; and

monitoring pressure after the baseline pressure measurement has been taken.

10. A method as claimed in claim 9 , wherein

monitoring pressure after the baseline pressure measurement has been taken comprises monitoring pressure for at least one minute after the baseline pressure measurement has been taken.

11. A method as claimed in claim 9 , further comprising the steps of:

pulling the syringe plunger while monitoring pressure in the fluid passage after the baseline pressure measurement has been taken.

12. A method as claimed in claim 7 , wherein the controller is located within the implanted infusion device.

13. A method as claimed in claim 7 , wherein the controller is part of a remote control.

14. A method as claimed in claim 4 , further comprising the step of:

pushing the syringe plunger while monitoring pressure in the fluid passage after the baseline pressure measurement has been taken.

15. A method as claimed in claim 5 , further comprising the step of:

withdrawing the syringe plunger while monitoring pressure in the fluid passage after the baseline pressure measurement has been taken.

16. A method for use with an implanted infusion device, a controller, and a syringe that is not part of the implanted infusion device, the implanted infusion device including an implanted reservoir refill port, an implanted reservoir connected to the implanted reservoir refill port, an implanted pump mechanism connected to the implanted reservoir, an implanted outlet port configured to have a catheter connected thereto, a fluid passage between the implanted pump mechanism and the implanted outlet port that connects the implanted pump mechanism to the implanted outlet port, an implanted catheter access port connected to the fluid passage at a location between the implanted pump mechanism and the implanted outlet port, and a pressure sensor connected to the passage at a location between the implanted pump mechanism and the implanted outlet port, the controller being operably connected to the pressure sensor, and the syringe including a plunger and a hypodermic needle, the method comprising the steps of:

sensing a baseline pressure in the fluid passage with the pressure sensor;

continuing to sense pressure with the pressure sensor after the baseline pressure has been sensed;

determining, with the controller, that the hypodermic needle has entered the implanted catheter access port in response to a predetermined decrease in pressure in the fluid passage from the baseline pressure in the fluid passage; and

providing an audible and/or visible indication that the catheter access port has been accessed in response to a determination that the hypodermic needle has entered the catheter access port.

17. A method as claimed in claim 16 , further comprising the step of:

initiating a catheter access port monitoring period in response to a signal from a remote device;

wherein the predetermined decrease in pressure from a baseline pressure comprises a predetermined decrease in pressure from a baseline pressure that occurs during the catheter access port monitoring period.

18. A method as claimed in claim 16 , further comprising the steps of:

taking a baseline pressure measurement; and

monitoring pressure after the baseline pressure measurement has been taken.

19. A method as claimed in claim 18 , wherein

monitoring pressure after the baseline pressure measurement has been taken comprises monitoring pressure for at least one minute after the baseline pressure measurement has been taken.

20. A method as claimed in claim 18 , further comprising the steps of:

pulling the syringe plunger while monitoring pressure in the fluid passage after the baseline pressure measurement has been taken.

21. A method as claimed in claim 16 , wherein the controller is located within the implanted infusion device.

22. A method as claimed in claim 16 , wherein the controller is part of a remote control.

Assignments (11)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
RELEASE OF SECURITY INTEREST Recorded Jul 14, 2025
From: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
To: MEDTRONIC MINIMED, INC.
Reel/Frame 071698/0639 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2021
From: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
To: MEDTRONIC MINIMED, INC.
Reel/Frame 057962/0741 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2019
From: MEDALLION THERAPEUTICS, INC.
To: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 051287/0120 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2014
From: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
To: MEDALLION THERAPEUTICS, INC.
Reel/Frame 032892/0067 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SCHEDULE WHICH REFLECTED PATENT NUMBER AS 8,327,041 AND SHOULD HAVE BEEN REFLECTED AS 8,372,041. PREVIOUSLY RECORDED ON REEL 032815 FRAME 0188. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded May 6, 2014
From: MEDALLION THERAPEUTICS, INC.
To: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 032827/0478 →
SECURITY INTEREST Recorded May 2, 2014
From: MEDALLION THERAPEUTICS, INC.
To: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 032815/0188 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2014
From: INFUSION SYSTEMS, LLC
To: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 032675/0307 →
CHANGE OF NAME Recorded Apr 14, 2008
From: ADVANCED BIONICS CORPORATION
To: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Reel/Frame 020796/0264 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2008
From: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
To: INFUSION SYSTEMS, LLC
Reel/Frame 020329/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2007
From: SHELTON, BRIAN MICHAEL; RING, LAWRENCE S.; GIBSON, SCOTT R.; ROSS, PAUL EDWARD
To: ADVANCED BIONICS CORPORATION
Reel/Frame 019398/0076 →